Search Results - "Rakaee, M."

Virtual Evaluation of Hematoxylin & Eosin via Digital Pathology Survey (VEED) Project: Results from a Non-Inferiority Study of a Tabs-Based Staining Method.

Authors: Nibid, Lorenzo Iannaccone, Erica Maffei, Elisabetta et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1868. 12p.

Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma.

Authors: Nassar AH Kim C Adeyelu T et al.

Source: Nature communications [Nat Commun] 2025 Aug 19; Vol. 16 (1), pp. 7717. Date of Electronic Publication: 2025 Aug 19.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A Change of Hallmark: An Update.

Authors: Donnem, Tom Kerr, David Nikitenko, Leonid L et al.

Source: Cells (2073-4409). Oct2025, Vol. 14 Issue 19, p1490. 10p.

A myeloid immunosuppressive phenotype defines primary refractoriness to atezolizumab plus bevacizumab in hepatocellular carcinoma.

Authors: Lombardi P Ramon-Gil E Raja RQ et al.

Source: Journal of hepatology [J Hepatol] 2026 Jun 15. Date of Electronic Publication: 2026 Jun 15.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8503886 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0641 (Electronic) Linking ISSN: 01688278 NLM ISO Abbreviation: J Hepatol Subsets: MEDLINE

Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status.

Authors: Førde D Kilvær T Pedersen MI et al.

Source: Frontiers in oncology [Front Oncol] 2025 Sep 25; Vol. 15, pp. 1606933. Date of Electronic Publication: 2025 Sep 25 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

CD3⁺RUNX3⁺ lymphocyte density; an independent prognostic factor in colon and lung adenocarcinoma but not in lung squamous cell carcinoma.

Authors: Kilvaer TK Førde D Paulsen EE et al.

Source: Scientific reports [Sci Rep] 2026 Feb 05; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 05.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice.

Authors: Jamaly, Simin Rakaee, Mehrdad Ichinose, Kunihiro et al.

Source: International Journal of Molecular Sciences. Apr2026, Vol. 27 Issue 7, p3190. 9p.

Breast Cancer Hormone Receptor Status Determination from H&E-Stained Biopsy Images Using Pixel-Level Classifiers.

Authors: Wu, Shuyang Nearchou, Ines P. Prost, Sandrine et al.

Source: Cancers. Jul2026, Vol. 18 Issue 13, p2085. 15p.

A radio-pathological fusion model for predicting PD-L1 expression and immunotherapy response in non-small cell lung cancer.

Authors: Huang, Dingpin Xu, Fangyi Gan, Yi et al.

Source: Insights into Imaging. 6/15/2026, Vol. 17 Issue 1, p1-14. 14p.

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials.

Authors: Wang, Zhaojun Fang, Yiran Huang, Xiatong et al.

Source: Advanced Science. 1/14/2026, Vol. 13 Issue 3, p1-20. 20p.

High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC.

Authors: Førde D Kilvær T Pedersen MI et al.

Source: Frontiers in immunology [Front Immunol] 2024 Dec 19; Vol. 15, pp. 1504220. Date of Electronic Publication: 2024 Dec 19 (Print Publication: 2024).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Definitive Radiotherapy With or Without Chemotherapy After Planned Neoadjuvant Chemoimmunotherapy in Stages II to III NSCLC: An International Multicenter Retrospective Study.

Authors: Adib E Nassar AH Lee KN et al.

Source: JTO clinical and research reports [JTO Clin Res Rep] 2025 Dec 29; Vol. 7 (4), pp. 100949. Date of Electronic Publication: 2025 Dec 29 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101769967 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3643 (Electronic) Linking ISSN: 26663643 NLM ISO Abbreviation: JTO Clin Res Rep Subsets: PubMed not MEDLINE

Evaluation of the Proliferation Marker Ki-67 for Improved Risk Stratification of Prostate Cancer Patients Under Active Surveillance.

Authors: Schütz, Viktoria Rothermel, Maresa Kaczorowski, Adam et al.

Source: Diagnostics (2075-4418). Apr2026, Vol. 16 Issue 7, p975. 18p.

Tertiary Lymphoid Structures Are Associated with Favorable Clinical Outcomes and Negatively Correlated with Cancer-Associated Fibroblasts in Esophageal Cancer.

Authors: Kunitomo, Tomoyoshi Noma, Kazuhiro Nishiwaki, Noriyuki et al.

Source: Cancers. Oct2025, Vol. 17 Issue 20, p3351. 16p.

Dysregulation of microRNAs and Centromere Protein Genes in Prostate Cancer and Metastatic Progression.

Authors: Somuncu, Makbule Nihan Karalezli, İlknur Göger, Yunus Emre et al.

Source: Urology Research & Practice. 2026, Vol. 52, p1-9. 9p.

Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and In Silico Characterization.

Authors: Albarracín-Navas, Lorena Lara-Salas, Nicolás I. Alarcon-Roa, Javier H. et al.

Source: Life (2075-1729). Jan2026, Vol. 16 Issue 1, p95. 18p.

Low-Cost Lung Cancer Classification in WSIs Using a Foundation Model and Evolving Prototypes.

Authors: Oskouei, Soroush Pedersen, André Valla, Marit et al.

Source: Algorithms. Dec2025, Vol. 18 Issue 12, p769. 19p.

AI driven pre-regulatory validation of PD-L1 analysis in lung cancer.

Authors: Makhlouf, Yasmine Maxwell, Perry O’Reilly, Paul et al.

Source: Scientific Reports. 11/28/2025, Vol. 15 Issue 1, p1-13. 13p.

Deep Learning Model-Based Architectures for Lung Tumor Mutation Profiling: A Systematic Review.

Authors: Ortuño-Miquel, Samanta Roca, Reyes Alenda, Cristina et al.

Source: Cancers. Nov2025, Vol. 17 Issue 22, p3619. 18p.

DeepCMS: A Feature Selection-Driven Model for Cancer Molecular Subtyping with a Case Study on Testicular Germ Cell Tumors.

Authors: Khan, Mehwish Wahid Ahmed, Ghufran Shahzad, Muhammad et al.

Source: Diagnostics (2075-4418). Nov2025, Vol. 15 Issue 21, p2730. 15p.